Neuberger Berman Group LLC Abcam PLC Transaction History

Neuberger Berman Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$21.54 - $24.41 $26.4 Million - $29.9 Million	-1,223,853 Reduced 32.77%	2,510,987 $56.8 Million
Q2 2023 Aug 11, 2023	BUY	$12.62 - $24.47 $7 Million - $13.6 Million	554,344 Added 17.43%	3,734,840 $91.4 Million
Q1 2023 May 12, 2023	SELL	$12.98 - $17.1 $779,189 - $1.03 Million	-60,030 Reduced 1.85%	3,180,496 $42.8 Million
Q4 2022 Feb 13, 2023	BUY	$13.92 - $17.0 $41 Million - $50.1 Million	2,947,432 Added 1005.63%	3,240,526 $50.4 Million
Q3 2022 Nov 15, 2022	BUY	$13.36 - $16.75 $241,335 - $302,572	18,064 Added 6.57%	293,094 $4.39 Million
Q2 2022 Aug 15, 2022	BUY	$12.69 - $19.25 $1,510 - $2,290	119 Added 0.04%	275,030 $3.98 Million
Q1 2022 May 13, 2022	BUY	$15.5 - $23.89 $4.26 Million - $6.57 Million	274,911 New	274,911 $5.03 Million

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

Stay updated on Neuberger Berman Group LLC with notifications on news.